personalized viral vaccine (EpiCentrx)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepersonalized viral vaccine (EpiCentrx)

Drug Alias NameAdAPT-PSV

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccineBiologics > Antigen > Tumor antigen +[5]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesEpicentrx Inc

China Registration ClassN/A

Develop Information

Active CompaniesEpicentrx Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A